Cost-effectiveness of Daclatasvir in Combination with Sofosbuvir for the Treatment of Subjects with Genotype 3 Chronic Hepatitis C Infection in the United States

被引：0
作者：
Thibault, Catherine St-Laurent [1 ]
Moorjaney, Divya [1 ]
Ganz, Michael [1 ]
Sill, Bruce E. [2 ]
Hede, Shalini [2 ]
Yuan, Yong [2 ]
Kalsekar, Anupama [2 ]
Gorsh, Boris [2 ]
机构：
[1] Evidera, Modeling & Simulat, St Laurent, PQ, Canada
[2] Bristol Myers Squibb Co, Plainsboro, NJ USA
来源：
HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1461
引用
收藏
页码：923A / 923A
页数：1
相关论文
共 50 条
[21]   Cost-effectiveness of treatment for chronic hepatitis C infection [J].
Bernstein, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (15) :1993-1993
[22]   Ledipasvir/Sofosbuvir versus Daclatasvir/Sofosbuvir for the Treatment of Chronic Hepatitis C Genotype 4 Patients [J].
Abdelaty, Lamiaa N. ;
Elnaggar, Ahmed A. ;
Said, Amira A. ;
Hussein, Raghda R. S. .
CURRENT DRUG SAFETY, 2020, 15 (01) :53-60
[23]   Cost-effectiveness of sofosbuvir in the treatment of patients with hepatitis C [J].
Leleu, H. ;
Blachier, M. ;
Rosa, I. .
JOURNAL OF VIRAL HEPATITIS, 2015, 22 (04) :376-383
[24]   Cost-effectiveness of elbasvir/grazoprevir plus sofosbuvir for the treatment of chronic HCV genotype 3 infection in Argentina [J].
Bissio, E. ;
Nwankwo, C. ;
Corman, S. ;
Monsanto, H. ;
Montes, J. L. .
JOURNAL OF HEPATOLOGY, 2018, 68 :S189-S190
[25]   ESTIMATING THE COST-EFFECTIVENESS OF DACLATASVIR PLUS SOFOSBUVIR IN TREATMENT-NAIVE, TREATMENT-EXPERIENCED AND INTERFERON-INELIGIBLE/INTOLERANT PATIENTS WITH ADVANCED CHRONIC HEPATITIS C GENOTYPE 1 INFECTION [J].
McEwan, P. ;
Webster, S. ;
Ward, T. ;
Kalsekar, A. ;
Yuan, Y. ;
Brenner, M. .
JOURNAL OF HEPATOLOGY, 2015, 62 :S627-S628
[26]   The Cost-effectiveness of Screening for Chronic Hepatitis B Infection in the United States [J].
Eckman, Mark H. ;
Kaiser, Tiffany E. ;
Sherman, Kenneth E. .
CLINICAL INFECTIOUS DISEASES, 2011, 52 (11) :1294-1306
[27]   Cost-effectiveness of Sofosbuvir plus Ledipasvir Antiviral Treatment for Elderly Patients with Chronic Hepatitis C Genotype 1 [J].
Ciaccio, Antonio ;
Cortesi, Paolo ;
Bellelli, Giuseppe ;
Rota, Matteo ;
Rota, Monica ;
Mantovani, Lorenzo G. ;
Annoni, Giorgio ;
Strazzabosco, Mario .
HEPATOLOGY, 2015, 62 :919A-919A
[28]   Cost-effectiveness of sofosbuvir for the treatment of chronic hepatitis C infected patients in the UK [J].
Cure, Sandrine ;
Guerra, Ines ;
Dusheiko, Geoffrey M. .
HEPATOLOGY, 2014, 60 :660A-660A
[29]   Cost-effectiveness of sofosbuvir for the treatment of chronic hepatitis C-infected patients [J].
Cure, S. ;
Guerra, I. ;
Dusheiko, G. .
JOURNAL OF VIRAL HEPATITIS, 2015, 22 (11) :882-889
[30]   COST-EFFECTIVENESS ANALYSIS OF SOFOSBUVIR FOR GENOTYPE 2 HEPATITIS C IN GREECE [J].
Athanasakis, K. ;
Boubouchairopoulou, N. ;
Kyriopoulos, I ;
Tsoulas, C. ;
Tzanakis, B. ;
Kyriopoulos, J. .
VALUE IN HEALTH, 2016, 19 (07) :A415-A415
12345